These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28938089)

  • 1. Drug Discovery and Chemical Biology of Cancer Epigenetics.
    Ribich S; Harvey D; Copeland RA
    Cell Chem Biol; 2017 Sep; 24(9):1120-1147. PubMed ID: 28938089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
    Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
    Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
    Mohammad HP; Barbash O; Creasy CL
    Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in cancer stem cells.
    Toh TB; Lim JJ; Chow EK
    Mol Cancer; 2017 Feb; 16(1):29. PubMed ID: 28148257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs.
    Yu J; Xie T; Wang Z; Wang X; Zeng S; Kang Y; Hou T
    Drug Discov Today; 2019 Dec; 24(12):2323-2331. PubMed ID: 31494187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
    Schneider-Stock R; Ocker M
    IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
    Gnyszka A; Jastrzebski Z; Flis S
    Anticancer Res; 2013 Aug; 33(8):2989-96. PubMed ID: 23898051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDITORIAL: Medicinal Chemistry of Molecular and Epigenetic Targets and Dug Development.
    Zhang L
    Curr Top Med Chem; 2017; 17(15):1669. PubMed ID: 28589850
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond regulations at DNA levels: A review of epigenetic therapeutics targeting cancer stem cells.
    Zhang S; Gong Y; Li C; Yang W; Li L
    Cell Prolif; 2021 Feb; 54(2):e12963. PubMed ID: 33314500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies.
    Pechalrieu D; Etievant C; Arimondo PB
    Biochem Pharmacol; 2017 Apr; 129():1-13. PubMed ID: 27956110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of novel epigenetic molecular-targeting agents].
    Sowa Y; Sakai T
    Nihon Rinsho; 2015 Aug; 73(8):1263-7. PubMed ID: 26281676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives.
    Song Y; Wu F; Wu J
    J Hematol Oncol; 2016 Jun; 9(1):49. PubMed ID: 27316347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked for death: targeting epigenetic changes in cancer.
    Pfister SX; Ashworth A
    Nat Rev Drug Discov; 2017 Apr; 16(4):241-263. PubMed ID: 28280262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conference scene: 2nd cancer epigenetics conference.
    Smith CL
    Epigenomics; 2013 Apr; 5(2):123-30. PubMed ID: 23566090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Methyltransferase 3A: A Significant Target for the Discovery of Inhibitors as Potent Anticancer Drugs.
    Feng Q; Duan H; Zhou X; Wang Y; Zhang J; Zhang H; Chen G; Bao X
    Mini Rev Med Chem; 2024; 24(5):507-520. PubMed ID: 37642180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays.
    Shao Z; Xu P; Xu W; Li L; Liu S; Zhang R; Liu YC; Zhang C; Chen S; Luo C
    Bioorg Med Chem Lett; 2017 Jan; 27(2):342-346. PubMed ID: 27899265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer treatment of the future: inhibitors of histone methyltransferases.
    Spannhoff A; Sippl W; Jung M
    Int J Biochem Cell Biol; 2009 Jan; 41(1):4-11. PubMed ID: 18773966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.